Caritas is launching a new global campaign  “HAART for Children: Greater Access to Pediatric HIV and TB testing and treatment”, urging governments and pharmaceutical companies to develop the HIV/AIDS and TB treatment that could save the lives of 800 children a day from AIDS and TB. HAART stands for Highly Active Anti-Retroviral Therapy (HAART), the term given to treatment regimens to aggressively suppress viral replication and slow the progress of HIV disease.